DRD3
HGNC:3024 · SaudiVarKB evidence summary derived from retained literature mentions.
5Gene mentions
5Publications
7Linked variants
4Associated phenotypes
Associated phenotypes
Co-mentioned in DRD3 publications| Phenotype | Identifier | Articles | Mentions |
|---|---|---|---|
| autism spectrum disorder | HP:0000729 | 2 | 2 |
| Alzheimer disease | — | 1 | 1 |
| diabetes mellitus | — | 1 | 1 |
| neurodevelopmental disorder | HP:0012759 | 1 | 1 |
Linked variants
Variants normalized to DRD3Population context
Reported in the same publications| Country / region | Group | Cohort | Articles |
|---|---|---|---|
| Saudi Arabia | — | — | 1 |
| Not specified | — | 100 | 1 |
Supporting publications
5 records- 2026Biomarker Variants of Dopamine Receptor Genes Influence the Binding Interaction Between Dopamine Receptor and Risperidone.Drug design, development and therapy1 mentions
- 2025Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches.Computational biology and chemistry1 mentions
- 2024The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.European journal of clinical pharmacology1 mentions
- 2024Gene-gene and gene-environmental interaction of dopaminergic system genes in Pakistani children with attention deficit hyperactivity disorder.Saudi journal of biological sciences1 mentions
- 2016Gene-gene interactions between DRD3, MRP4 and CYP2B6 polymorphisms and its influence on the pharmacokinetic parameters of efavirenz in HIV infected patients.Drug metabolism and pharmacokinetics1 mentions